|
|
Clinical study of combined use of three drugs in the treatment of overlapping functional dyspepsia of diarrhea induced irritable bowel syndrome |
LIU Ning RAO Jian-guo |
Department of Internal Medicine,People′s Hospital of Jinxi County,Jiangxi Province,Jinxi344800,China |
|
|
Abstract Objective To study the clinical effect of three drugs combined with diarrhea-predominant irritable bowel syndrome on functional dyspepsia.Methods Sixty patients with diarrhea-predominant irritable bowel syndrome with functional dyspepsia who were admitted to our hospital from September 2015 to September 2017 were selected as subjects and were randomly divided into two groups by lottery,with 30 cases in each group.Patients in the control group were given Montmorillonite Powder(3 g/time,3 times/d)+Domperidone(10 mg,3 times/d)pre-meal orally,patients in the observation group were given Mosapride(5 mg/time,3 times/d)on the above basis,oral 2 h after meal,4 weeks later,the clinical symptom scores,clinical efficacy,and adverse reactions of the two groups were compared before and after treatment.Results There was no statistically significant difference in clinical symptom scores between the two groups before treatment(P>0.05).Clinical symptom scores in the observation group after treatment was(1.26±0.19)points,which was significantly lower than those in the control group of(4.53±0.36)points,the difference was statistically significant(P<0.05).The total treatment efficiency in the observation group(96.67%)was significantly higher than the control group(70.00%),the difference was statistically significant(P<0.05).The total incidence of adverse reactions in the observation group(6.67%)was significantly lower than that in the control group(43.33%),the difference was statistically significant(P<0.05).Conclusion The combination of three drugs in the treatment of diarrhea-predominant irritable bowel syndrome with functional dyspepsia can effectively improve the patient′s clinical discomfort,has significant efficacy,safety,and is worthy of promotion.
|
|
|
|
|
[1] |
陈磊,陈莉丽,全俊,等.肠易激综合征与功能性消化不良重叠的治疗进展[J].胃肠病学和肝病学杂志,2014,23(3):350-352.
|
[2] |
康丽丽,唐艳萍.腹泻型肠易激综合征中医治疗研究进展[J].中国中西医结合外科杂志,2016,22(4):414-416.
|
[3] |
中华医学会消化病学分会胃肠动力学组.中国消化不良的诊治指南(2007)[J].中华全科医师杂志,2008,13(9):593-595.
|
[4] |
王陆军,于岩瀑,高树中,等.脐疗对腹泻型肠易激综合征模型大鼠影响的实验研究[J].中国中医基础医学杂志,2016,22(6):774-776.
|
[5] |
顾勇刚,乔春萍,黄云胜.安肠消痞汤治疗腹泻型肠易激综合征重叠功能性消化不良32例[J].中医药导报,2015,21(14):64-66.
|
[6] |
陈雪娥,王承党.奥替溴铵和匹维溴铵治疗84例腹泻型肠易激综合征的疗效和安全性[J].中华消化杂志,2016,36(5):343-346.
|
[7] |
王济邦.中西医结合治疗腹泻型肠易激综合征疗效观察[J].浙江医学,2016,38(2):144-145.
|
[8] |
陈磊,全俊,张旭东,等.老年人肠易激综合征并功能性消化不良与胃肠激素相关性研究[J].中华老年医学杂志,2015,34(4):394-396.
|
[9] |
赵梁,宋雯,朱萍,等.腹泻型肠易激综合征合并功能性消化不良肝郁脾虚证与胃肠激素相关性研究[J].中国中西医结合杂志,2014,34(10):1168-1172.
|
[10] |
刘建生,田怡,张晓红,等.复方阿嗪咪特治疗功能性消化不良重叠腹泻型肠易激综合征的研究[J].中国医师杂志,2013,15(3):396-398.
|
[11] |
赵梁,宋雯,朱萍,等.腹泻型肠易激综合征重叠功能性消化不良与精神心理、胃肠激素的相关性[J].中华消化杂志,2013,33(2):88-92.
|
[12] |
向贵英.肠易激综合征重叠功能性消化不良患者与其精神心理、胃肠激素相关性[J].热带医学杂志,2015,15(12):1671-1674.
|
[13] |
沈曼茹,颜美珠,陈炜,等.莫沙必利治疗便秘型肠易激综合征重叠功能性消化不良临床研究[J].临床消化病杂志,2013,25(1):10-12.
|
[14] |
陈建平,陈科.逍遥散联合匹维溴铵片治疗腹泻型肠易激综合征临床观察[J].河北中医,2016,38(2):239-242.
|
[15] |
于凤杰,彭宪星,刘芹,等.蒙脱石散联合多潘立酮治疗腹泻型肠易激综合征重叠功能性消化不良效果观察[J].临床消化病杂志,2017,29(4):252-254.
|
|
|
|